Purdue Pharma

October 05, 2007 -- Kentucky Attorney General Greg Stumbo today announced the filing of a lawsuit against Purdue Pharma, the manufacturer of OxyContin, a highly abused narcotic.

The lawsuit alleges that Purdue Pharma misrepresented the risks of using OxyContin and seeks to recover damages suffered state and county governments related to widespread addiction caused by the drug.

(Click here for a copy of the Complaint: http://tinyurl.com/2qyfky)    » read more »

September 28, 2007 -- Oregon Attorney General Hardy Myers today announced that the Department of Justice (DOJ) Medicaid Fraud Control Unit has reached a settlement with the Purdue Frederick Company, Inc., a New York Corporation ("Purdue Frederick") and Purdue Pharma L.P., a Delaware limited partnership ("Purdue") which are associated entities engaged in the manufacture, marketing and distribution of OxyContin, an extended-release form of the painkiller Oxycodone.    » read more »

Settlement resolves civil charges caused by company’s misbranding of OxyContin

September 21, 2007 -- TALLAHASSEE, FL – Florida Attorney General Bill McCollum today announced that his Medicaid Fraud Control Unit has joined a national settlement with the Purdue Frederick Company, Inc., a New York corporation, and Purdue Pharma, L.P. a Delaware Limited Partnership. The companies will pay more than $2 million to the State of Florida to resolve civil claims related to the manufacture, marketing and distribution of OxyContin.    » read more »

September 20, 2007 -- (Boise) - The State of Idaho has recovered $652,130 as a result of a civil settlement involving alleged misbranding of the prescription drug OxyContin, Idaho Attorney General Lawrence Wasden said today. Wasden said his office and the Idaho Department of Health and Welfare Medicaid Division joined in a multi-state settlement with two associated businesses engaged in the manufacture, marketing, and distribution of OxyContin, an extended-release form of Oxycodone.    » read more »

September 18, 2007 -- OLYMPIA – Washington Attorney General Rob McKenna announced today that the state's Medicaid program will be reimbursed nearly $2.7 million as part of a settlement with drug manufacturers Purdue Pharma and Purdue Frederick Company. The settlement stems from allegations the company improperly marketed the pain medication OxyContin to health providers.    » read more »

September 18, 2007 -- HARRISBURG - A $5,078,436 settlement has been reached with The Purdue Frederick Company, Inc. and Purdue Pharma, L.P., manufacturers of OxyContin, for improperly marketing the highly addictive pain medication to health care providers.

Pennsylvania Attorney General Tom Corbett said the money is part of a $160 million multi-state civil lawsuit settlement to compensate state and federal Medicaid programs for damages caused by the misbranding of OxyContin from 1995 through 2005.    » read more »

September 18, 2007 -- Carson City, NV - Nevada Attorney General Catherine Cortez Masto announced today that her office has reached a settlement with The Purdue Frederick Company, Inc., a New York corporation, and Purdue Pharma, L.P., a Delaware limited partnership, which are associated entities engaged in the manufacture, marketing, and distribution of OxyContin, an extended-release form of oxycodone.

Under the terms of the settlement, the State of Nevada recovered $1,047,787.19 to recoup damages to the Nevada Medicaid program as well as damages for investigative costs and penalties.    » read more »